Trial Profile
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2022
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine (Primary) ; Measles vaccine (Primary) ; Varicella vaccines (Primary)
- Indications Hepatitis A; Measles; Varicella zoster virus infections
- Focus Pharmacodynamics
- Acronyms MV/VV/Hep-AV
- 15 Mar 2020 Status changed from recruiting to active, no longer recruiting.
- 17 Feb 2020 Planned End Date changed from 1 Jun 2019 to 1 Dec 2022.
- 17 Feb 2020 Status changed from completed to recruiting.